NHS Framework Agreement, Branded Medicines for London and South of England and Bevacizumab for North of England and Midlands and East
Invitation to offer for NHS Framework Agreement, Branded Medicines for London and South of England. Offer ref number: CM/PHR/20/5598 Lot 01 - LONDON Branded Medicines - Tranche B. Period of Framework 01/09/21 - 31/08/23 with option to extend for a period of 24 months. Lot 02 - LONDON Branded Medicines - Annual Tranche. Period of framework 01/09/21 - 31/08/22 with option to extend for period of 12 months. Lot 03 - SOUTH of England Tranche A. Period of Framework: 01/09/21 - 31/08/23 with option for a period of 24 mon...
Buyer
NHS England
Value
£441,994,547
Published
30 Apr 2021
Closes
4 Jun 2021
Procurement details
Source
Contracts Finder
Region
United Kingdom
Procurement method
Open
Category
Goods
Contract starts
Not provided
Contract ends
Not provided
CPV classifications
33600000
Pharmaceutical products
Lots
Lot default NHS Framework Agreement, Branded Medicines for London and South of England and Bevacizumab for North of England and Midlands and East
£441,994,547
Invitation to offer for NHS Framework Agreement, Branded Medicines for London and South of England. Offer ref number: CM/PHR/20/5598 Lot 01 - LONDON Branded Medicines - Tranche B. Period of Framework 01/09/21 - 31/08/23 with option to extend for a period of 24 months. Lot 02 - LONDON Branded Medicines - Annual Tranche. Period of framework 01/09/21 - 31/08/22...
Delivery: East Midlands · United Kingdom, East of England · United Kingdom, Isle of Man, London · United Kingdom, North East · United Kingdom, North West · United Kingdom
Documents
Unlock document linkOpportunity notice on Contracts Finder
30 Apr 2021
Opportunity notice on Contracts Finder
Tender notice · Web page
Contains public sector information licensed under the Open Government Licence v3.0.